Ginkgo Bioworks Holdings, Inc. Class A (DNA) earnings

DNA earnings moved a median of -3.18% by the close. Quarterly and annual DNA reports and results, each read against the price at its own news timestamp. Back to the DNA overview →

28 measured DNA earnings events.

Where these DNA earnings landedvs 28 measured DNA earnings reactions
DNA earningsMiddle 50% · -8.13% to +3.35%Zero: 0.00%Median: -3.18%Median -3.18%-15.00%0+15.00%
Middle 50% of DNA earnings reactions-8.13% to +3.35%
Median reaction (to close)-3.18%
Measured reactions28
Point-in-time · zero look-ahead

Half of the 28 DNA earnings events with a measured close landed between -8.13% and +3.35%; 39% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q Ginkgo Bioworks Holdings For: Jun 30SEC filing · Form 10-Q-8.24%-4.09%
Form 10-Q Ginkgo Bioworks Holdings For: Mar 31SEC filing · Form 10-Q+4.65%+3.72%
Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous LabPress release+4.65%+3.72%
Ginkgo Bioworks Announces Date of First Quarter 2026 Results PresentationPress release+1.73%+12.35%
Form 10-K Ginkgo Bioworks Holdings For: Dec 31SEC filing · Form 10-K-2.65%-16.46%
Form 10-Q Ginkgo Bioworks Holdings For: Sep 30SEC filing · Form 10-Q-2.72%-13.02%
Ginkgo Bioworks Reports Third Quarter 2025 Financial ResultsPress release-2.72%-13.02%
Ginkgo Bioworks Announces Date of Third Quarter 2025 Results PresentationPress release+0.41%+7.09%
Form 10-Q Ginkgo Bioworks Holdings For: Jun 30SEC filing · Form 10-Q-2.53%-12.53%
Ginkgo Bioworks Reports Second Quarter 2025 Financial ResultsPress release-2.53%-12.53%
Ginkgo Bioworks Announces Date of Second Quarter 2025 Results PresentationPress release+0.70%+2.26%
Form 10-Q Ginkgo Bioworks Holdings For: Mar 31SEC filing · Form 10-Q-1.61%+8.35%
Ginkgo Bioworks Reports First Quarter 2025 Financial ResultsPress release-1.61%+8.35%
Ginkgo Bioworks Announces Date of First Quarter 2025 Results PresentationPress release-0.42%+3.22%
Form 10-K Ginkgo Bioworks Holdings For: Dec 31SEC filing · Form 10-K+1.67%+1.22%
Form 10-Q Ginkgo Bioworks Holdings For: Sep 30SEC filing · Form 10-Q+3.30%-5.39%
Ginkgo Bioworks Reports Third Quarter 2024 Financial ResultsPress release+3.30%-5.39%
Ginkgo Bioworks Announces Date of Third Quarter 2024 Results PresentationPress release+0.27%+6.11%
Form 10-Q Ginkgo Bioworks Holdings For: Jun 30SEC filing · Form 10-Q+2.32%-12.84%
Ginkgo Bioworks Reports Second Quarter 2024 Financial ResultsPress release+2.32%-12.84%
Ginkgo Bioworks Announces Date of Second Quarter 2024 Results PresentationPress release-1.32%-2.27%
Form 10-Q Ginkgo Bioworks Holdings For: Mar 31SEC filing · Form 10-Q-2.04%-6.06%
Ginkgo Bioworks Reports First Quarter 2024 Financial ResultsPress release-2.04%-6.06%
Ginkgo Bioworks Announces Date of First Quarter 2024 Results PresentationPress release-0.67%-1.94%
Form 10-K Ginkgo Bioworks Holdings For: Dec 31SEC filing · Form 10-K-3.52%+0.78%
Form 10-Q Ginkgo Bioworks Holdings For: Sep 30SEC filing · Form 10-Q-1.11%-6.67%
Ginkgo Bioworks Reports Third Quarter 2023 Financial ResultsPress release-1.11%-6.67%
Ginkgo Bioworks Announces Date of Third Quarter 2023 Results PresentationPress release-1.81%-1.45%
That’s how DNA usually reacts to earnings — get an email when it moves on news →
Keep exploring

More DNA: analyst actions → · SEC filings → · DNA overview →